Calithera Biosciences logo

Calithera Biosciences CALA

report update icon

Quarterly report 2022-Q3
added 05-23-2026

Country

usaUSA

IPO year

2014

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

Shares

4.63 M

Market Cap[1]

$ 876 K

EBITDA (LTM)

-

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Reata Pharmaceuticals Reata Pharmaceuticals
RETA
- - $ 6.29 B Nasdaq Global Market,SPB usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
$ 119.1 2.14 % $ 7.74 B Nasdaq Global Market,SPB usaUSA
iTeos Therapeutics iTeos Therapeutics
ITOS
- - $ 411 M Nasdaq Global Market usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
$ 2.76 -8.35 % $ 36.8 M Nasdaq Global Market usaUSA
PolarityTE PolarityTE
PTE
- -0.82 % $ 1.78 M Nasdaq Capital Market usaUSA
Kronos Bio Kronos Bio
KRON
- 1.49 % $ 50.8 M Nasdaq Global Select Market usaUSA
Cullinan Management Cullinan Management
CGEM
$ 9.01 -2.86 % $ 543 M Nasdaq Global Select Market usaUSA
Sol-Gel Technologies Ltd. Sol-Gel Technologies Ltd.
SLGL
$ 54.13 2.46 % $ 151 M Nasdaq Global Select Market israelIsrael
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Trevena Trevena
TRVN
- -46.58 % $ 31.8 M Nasdaq Capital Market usaUSA
Molecular Templates Molecular Templates
MTEM
- -23.43 % $ 495 K Nasdaq Capital Market usaUSA
Oncorus Oncorus
ONCR
- -8.54 % $ 3.19 M Nasdaq Global Market usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
$ 0.07 9.81 % $ 855 K Nasdaq Global Select Market,SPB usaUSA
Novan Novan
NOVN
- -24.84 % $ 2.64 M Nasdaq Capital Market usaUSA
CohBar CohBar
CWBR
- -15.44 % $ 2.2 M Nasdaq Capital Market usaUSA
NeuBase Therapeutics NeuBase Therapeutics
NBSE
- -1.56 % $ 12.3 M Nasdaq Global Select Market usaUSA
Epizyme Epizyme
EPZM
- - $ 249 M Nasdaq Global Select Market usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Scopus BioPharma Scopus BioPharma
SCPS
- -48.37 % $ 3.71 M Nasdaq Global Select Market usaUSA
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
- - $ 4.55 M Nasdaq Global Select Market irlandaIrlanda
Annovis Bio Annovis Bio
ANVS
$ 0.81 9.63 % $ 16.6 M NYSE American usaUSA
scPharmaceuticals scPharmaceuticals
SCPH
- - $ 218 M Nasdaq Global Select Market usaUSA
X4 Pharmaceuticals X4 Pharmaceuticals
XFOR
$ 3.02 -2.27 % $ 128 M Nasdaq Capital Market usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
- - $ 105 M Nasdaq Global Market usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
$ 0.52 -0.62 % $ 5.75 M Nasdaq Capital Market usaUSA
Athersys Athersys
ATHX
- 3.77 % $ 22.4 M Nasdaq Capital Market usaUSA
Global Blood Therapeutics Global Blood Therapeutics
GBT
- - $ 4.62 B Nasdaq Global Select Market,SPB usaUSA
Inozyme Pharma Inozyme Pharma
INZY
- - $ 207 M Nasdaq Global Select Market usaUSA
NanoString Technologies NanoString Technologies
NSTG
- -37.43 % $ 5.1 M Nasdaq Global Select Market usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
$ 0.36 5.82 % $ 2.83 M Nasdaq Global Market israelIsrael
Humanigen Humanigen
HGEN
- -81.12 % $ 4.28 M Nasdaq Global Select Market usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
$ 4.44 6.99 % $ 1.97 M Nasdaq Capital Market usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
- -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
Surface Oncology Surface Oncology
SURF
- - $ 59.7 M Nasdaq Global Select Market usaUSA
Sierra Oncology Sierra Oncology
SRRA
- -0.05 % $ 1.34 B Nasdaq Global Select Market canadaCanada
Gilead Sciences Gilead Sciences
GILD
$ 168.96 -0.77 % $ 210 B Nasdaq Global Select Market,SPB usaUSA
Vaccinex Vaccinex
VCNX
- -61.37 % $ 654 K Nasdaq Global Select Market usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
- -19.68 % $ 18.4 M Nasdaq Capital Market canadaCanada
Jounce Therapeutics Jounce Therapeutics
JNCE
- - $ 98.4 M Nasdaq Global Select Market usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
$ 0.96 -4.95 % $ 10.8 M Nasdaq Capital Market usaUSA
Fortress Biotech Fortress Biotech
FBIO
$ 1.89 3.85 % $ 52.7 M Nasdaq Capital Market usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K NYSE American usaUSA
Longeveron Longeveron
LGVN
$ 1.93 -8.53 % $ 33.9 B Nasdaq Global Select Market usaUSA
Mersana Therapeutics Mersana Therapeutics
MRSN
- - $ 3.56 B Nasdaq Global Select Market usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
$ 6.51 14.22 % $ 438 B Nasdaq Capital Market britainBritain
CymaBay Therapeutics CymaBay Therapeutics
CBAY
- - $ 3.45 B Nasdaq Global Select Market usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
- - $ 384 M Nasdaq Global Select Market britainBritain
Allakos Allakos
ALLK
- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.